The FDA has cleared for marketing GelSpray Liquid Bandage. The product is a spray-on treatment for wounds -- including combat wounds -- according to a news release from Rutgers, the State University of New Jersey. The product releases polymers from a two-barreled syringe. The polymers mix into a "gel-based dressing that frontline combat soldiers can apply to their own wounds," states the Rutgers news release. Rutgers' Center for Military Biomaterials Research collaborated with BioCure, a company based in Norcross, Ga., to create the product. BioCure will market the product.
